Supply Chain

Fitch: New drug approvals off pace from 2017

The FDA has so far approved 44 percent fewer new drugs in 2018 than a year prior, according to a report from Fitch Ratings. By Mackenzie Bean - 6/6/18

3 steps to create a clinically integrated supply chain

Sponsored

In a world of narrowing margins and reimbursements, the supply chain is a proven target for reducing waste and saving money. Supply chain professionals work diligently to improve not only the price of products, but also seek innovative new ways to identify and reduce supply chain waste, such as product standardization and inventory management automation.

FDA exempts select genetic risk tests from 510(k) requirements

The FDA has exempted some genetic health risk assessments from the agency's premarket notification — or 510(k) — requirements, effective June 5. By Jessica Kim Cohen - 6/5/18
Price of estrogen drugs jumped 200% in 4 years: 5 takeaways

The price of estrogen replacement therapies used to treat menopause symptoms doubled between 2014 and 2018, according to an analysis from GoodRx. By Mackenzie Bean - 6/5/18

Podcast Sneak Peak: Insights from a Health System Leader on what makes a Champion of Change in Supply Chains

Sponsored

In a recent interview, Joe Swartz, the administrative director of business transformation for Franciscan St. Francis Health, spoke about his organization’s ten years of effort in engaging every staff member in “kaizen,” or continuous improvement.

FDA confirms 5 more patient deaths linked to balloon obesity devices: 5 things to know

The FDA alerted healthcare providers June 4 about five more deaths of patients using two brands of fluid-filled intragastric balloon systems to treat obesity. By Alia Paavola - 6/5/18
Hospira recalls opioid overdose antidote

Drugmaker Hospira issued a nationwide recall for two lots of its injectable opioid overdose antidote Naloxone over the potential presence of embedded and loose particulate matter on the syringe plunger. By Alia Paavola - 6/5/18
Interactive Infographic: Why the OR Supply Chain is Ready for Change

The growing risks, costs, and frustrations caused by OR supply chain inefficiencies now pose more serious consequences than ever before. By Lisa Zierten, Director of Marketing for Hospital Services at Cardinal Health - 6/4/18
3 ways FDA seeks to modernize its drug approval office

The FDA plans to modernize its Center for Drug Evaluation and Research's Office of New Drugs, which is responsible for reviewing and approving new medications. By Mackenzie Bean - 6/4/18

Tips for efficient inventory management in the OR: 4 thoughts from a Cardinal Health leader

Inefficient inventory and supply chain management processes can be a significant money drain for ASCs, which already function on tight margins. By Mackenzie Bean - 6/4/18
North Carolina VA hospital purchased over $1.3 million in supplies it never used

The Durham (N.C.) Veterans Affairs Medical center purchased nearly $1.4 million in supplies in 2014 that were sent to a storage facility and never unpacked, according to Stars and Stripes. By Leo Vartorella - 6/4/18
Population health: A supply chain problem?

A decade ago, the Institute for Healthcare Improvement coined the term the Triple Aim and outlined its respective components. By Karen Conway, MSHCD, CMRP, Vice President, Healthcare Value, GHX - 6/1/18
7 latest FDA approvals

Here are the seven latest drugs or medical devices approved by the FDA since May 24. By Mackenzie Bean - 6/1/18

FDA greenlights first artificial iris in US

The FDA approved the first standalone prosthetic iris in the U.S. May 30. By Mackenzie Bean - 6/1/18
FDA OKs Xeljanz for ulcerative colitis

The FDA on May 30 expanded the approval for Pfizer's drug Xeljanz. By Mackenzie Bean - 6/1/18
7 Nebraska troopers relay lifesaving drug 540 miles to Colorado hospital

Seven Nebraska patrolmen helped relay a hard-to-find drug 540 miles from Omaha-based University of Nebraska Medical Center to a hospital in Colorado after stormy weather prevented the medication from being flown to its destination, according to a KWBE report. By Alia Paavola - 6/1/18
Global antibiotic shortages are fueling superbugs: 5 report findings

Global antibiotic shortages, caused by a fragile drug supply chain, are contributing to the rise of multidrug-resistant bacteria known as superbugs, according to a report from the Access to Medicine Foundation. By Mackenzie Bean - 5/31/18
Trump: Drug companies will announce 'massive' drug price cuts in 2 weeks

President Donald Trump expects pharmaceutical companies to significantly lower drug prices over the next few weeks, according to Reuters. By Mackenzie Bean - 5/31/18
10 most-read supply chain stories in May

How Boston-based Massachusetts General Hospital is dealing with the ongoing intravenous opioid shortage most captured readers' attention in May. By Mackenzie Bean - 5/31/18
FDA OKs hormone therapy for vaginal condition tied to menopause: 4 things to know

The FDA approved TherapeuticsMD's hormone therapy Imvexxy for a vaginal condition linked to low estrogen levels during menopause, the company announced May 30. By Mackenzie Bean - 5/30/18
Sanofi responds to Roseanne's Ambien claim: Racism not a known side effect of our drugs

Actress Roseanne Barr claims her controversial tweet about Valerie Jarrett, a White House aide during the Obama administration, was due to her taking Sanofi's insomnia drug Ambien, reports CNN. By Mackenzie Bean - 5/30/18
How Amazon's latest patent would let customers interact with delivery drones

Amazon on May 29 earned a patent outlining the various methods its delivery drones could use to signal their approach and interact with customers expecting packages, reports GeekWire. By Mackenzie Bean - 5/30/18

Page 9 of 50

«
Prev
4
5
6
7
8
9
10
11
12
13
Next
»

Copyright © 2018 Becker's Healthcare. All Rights Reserved. Interested in linking to or reprinting our content? View our policies by clicking here.